1. Use of MRI and Ga-68 DOTATATE for the detection of neuroendocrine liver metastases
- Author
-
John Parker, Maera Haider, Alexander Goehler, Andrea J. Bullock, Brian G. Jiang, and Leo L. Tsai
- Subjects
medicine.medical_specialty ,Radiological and Ultrasound Technology ,business.industry ,Urology ,Gastroenterology ,Mean age ,Retrospective cohort study ,Hepatology ,medicine.disease ,Liver mri ,Metastasis ,Frequency detection ,Internal medicine ,medicine ,Medical imaging ,Radiology, Nuclear Medicine and imaging ,Detection rate ,Nuclear medicine ,business - Abstract
To compare detection rates of NET liver metastases of MRI and Ga-68-DOTATATE PET/CT to provide more clarity when selecting diagnostic imaging tests for NET staging. In this IRB-approved single-institution retrospective study, all patients with pathology-proven NET who underwent Ga-68-DOTATATE and MRI scans within 8 weeks of each other (3/2017–2/2020) were reviewed. Number of metastases for each patient on diffusion-weighted imaging (DWI), dynamic contrast-enhanced (DCE) MRI, and Ga-68 DOTATATE were recorded by two blinded radiologists, followed by consensus review with two separate blinded readers for MRI and nuclear medicine. Per-lesion and -modality scoring at each lesion location were then performed in consensus. Per-patient linear regression was performed comparing MRI and Ga-68 DOTATATE detection rates for each reader and in consensus, and per-lesion-matched pair difference means were used to compare detection frequency between modalities. 32 patients (mean age 59 years, 59.4% male) and 90 liver metastases were analyzed. Intraclass coefficients (ICC) [95% CI] between the two readers were 0.97 [0.95, 0.99], 0.89 [0.82, 0.94], and 0.98 [0.97, 0.99] for Ga-68 DOTATATE, DWI, and DCE, respectively. Matched per-lesion mean differences were + 0.17 ± 0.07 (p = 0.01) and + 0.22 ± 0.06 (p =
- Published
- 2021
- Full Text
- View/download PDF